• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血压控制不佳且药物依从性高的基层医疗患者的特征、药物组合及剂量

Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence.

作者信息

Grigoryan Larissa, Pavlik Valory N, Hyman David J

机构信息

Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX, USA.

Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX, USA.

出版信息

J Am Soc Hypertens. 2013 Nov-Dec;7(6):471-6. doi: 10.1016/j.jash.2013.06.004. Epub 2013 Jul 23.

DOI:10.1016/j.jash.2013.06.004
PMID:23890931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3883386/
Abstract

Most studies on the prevalence and determinants of resistant hypertension (RH) do not account for white coat hypertension, medication non-adherence, or use of suboptimal treatment dosages. We studied the characteristics, drug combinations, and dosages of patients on at least three antihypertensives of different classes who had uncontrolled blood pressure on 24-hour ambulatory blood pressure monitoring and high medication adherence measured by electronic monitoring. The data were collected as part of the baseline measures of a hypertension control trial. Of 140 monitored primary care patients, all with uncontrolled office blood pressure, 69 (49%) were on at least three antihypertensives of different classes. Of these 69, 15 (22%) were controlled on ambulatory blood pressure monitoring, 20 (29%) were uncontrolled and non-adherent, leaving only 34 (49%) adherent to their medications and having uncontrolled ambulatory hypertension (uncontrolled RH). Thirty-one (91%) of the 34 uncontrolled RH patients were prescribed a diuretic, of which 24 were on hydrochlorothiazide 25 mg. Less than half of the patients on angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, or calcium channel blocker were prescribed maximal doses of these agents. Half of the RH can be attributed to white coat effect and poor medication adherence, and all of the remaining patients were on apparently suboptimal drug combinations and/or dosages. Primary care physicians need to be educated regarding the optimal treatment of RH.

摘要

大多数关于难治性高血压(RH)患病率及决定因素的研究未考虑白大衣高血压、药物治疗依从性差或使用的治疗剂量未达最佳情况。我们研究了在24小时动态血压监测中血压未得到控制且通过电子监测显示药物治疗依从性高的、使用至少三种不同类别降压药的患者的特征、药物组合及剂量。这些数据是作为一项高血压控制试验的基线测量的一部分收集的。在140名接受监测的初级保健患者中,所有患者的诊室血压均未得到控制,其中69名(49%)患者使用了至少三种不同类别的降压药。在这69名患者中,15名(22%)在动态血压监测中血压得到控制,20名(29%)血压未得到控制且存在药物治疗不依从情况,仅剩下34名(49%)患者坚持用药但动态血压仍未得到控制(难治性RH)。34名难治性RH患者中有31名(91%)被处方了利尿剂,其中24名使用的是25毫克氢氯噻嗪。使用血管紧张素转换酶抑制剂、血管紧张素受体阻滞剂或钙通道阻滞剂的患者中,不到一半的患者被处方了这些药物的最大剂量。一半的难治性高血压可归因于白大衣效应和药物治疗依从性差,其余所有患者使用的药物组合和/或剂量显然未达最佳。需要对初级保健医生进行有关难治性高血压最佳治疗方法的培训。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1cf/3883386/e8c041d60fa3/nihms502126f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1cf/3883386/63662f5e5bcc/nihms502126f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1cf/3883386/e8c041d60fa3/nihms502126f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1cf/3883386/63662f5e5bcc/nihms502126f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1cf/3883386/e8c041d60fa3/nihms502126f2.jpg

相似文献

1
Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence.血压控制不佳且药物依从性高的基层医疗患者的特征、药物组合及剂量
J Am Soc Hypertens. 2013 Nov-Dec;7(6):471-6. doi: 10.1016/j.jash.2013.06.004. Epub 2013 Jul 23.
2
Resistant hypertension: a practical clinical approach.耐药性高血压:一种实用的临床方法。
J Hum Hypertens. 2013 Nov;27(11):657-62. doi: 10.1038/jhh.2013.34. Epub 2013 May 2.
3
Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice.固定剂量三联抗高血压药物组合可改善血压控制:从临床试验到临床实践。
Adv Ther. 2017 Apr;34(4):975-985. doi: 10.1007/s12325-017-0511-1. Epub 2017 Mar 15.
4
Resistant hypertension: an overview.难治性高血压:概述
Minerva Cardioangiol. 2018 Jun;66(3):337-348. doi: 10.23736/S0026-4725.17.04495-4. Epub 2017 Sep 5.
5
Resistant hypertension-defining the scope of the problem.耐药性高血压——定义问题的范围。
Prog Cardiovasc Dis. 2020 Jan-Feb;63(1):46-50. doi: 10.1016/j.pcad.2019.12.006. Epub 2019 Dec 19.
6
Measuring adherence to therapy in apparent treatment-resistant hypertension: a feasibility study in Irish primary care.评估爱尔兰初级保健中明显治疗抵抗性高血压患者的治疗依从性:一项可行性研究。
Br J Gen Pract. 2019 Aug 29;69(686):e621-e628. doi: 10.3399/bjgp19X705077. Print 2019 Sep.
7
[Prevalence of true resistant hypertension among uncontrolled hypertensive patients referred to a tertiary health care center].[转诊至三级医疗保健中心的血压控制不佳的高血压患者中真性难治性高血压的患病率]
Ann Cardiol Angeiol (Paris). 2016 Jun;65(3):191-6. doi: 10.1016/j.ancard.2016.04.003. Epub 2016 May 12.
8
Resistant hypertension: Diagnosis, evaluation, and treatment practical approach.耐药性高血压:诊断、评估和治疗实用方法。
Eur J Intern Med. 2024 May;123:23-28. doi: 10.1016/j.ejim.2023.12.026. Epub 2024 Jan 15.
9
Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.在单用地尔硫䓬治疗未达标的高血压患者中药物的额外降压作用:一项使用诊室和家庭血压监测的随机对照试验
Clin Exp Hypertens. 2006 Oct;28(7):655-62. doi: 10.1080/10641960600946429.
10
Misdiagnosis of resistant hypertension: Real frequency of true resistant hypertension in patients with suspected resistance to treatment.耐药性高血压的误诊:怀疑治疗抵抗的患者中真正耐药性高血压的真实频率。
Med Clin (Barc). 2018 Jan 12;150(1):20-23. doi: 10.1016/j.medcli.2017.06.046. Epub 2017 Aug 1.

引用本文的文献

1
Identifying pseudo-resistant hypertension and optimizing diuretic therapy for confirmed resistant cases in primary care.在基层医疗中识别假性难治性高血压并优化确诊难治性病例的利尿剂治疗。
Can Pharm J (Ott). 2024 Oct 3;157(6):334-340. doi: 10.1177/17151635241281511. eCollection 2024 Nov-Dec.
2
Prescribing patterns of antihypertensive medications: A systematic review of literature between 2010 and 2020.抗高血压药物的处方模式:2010年至2020年文献的系统综述
Explor Res Clin Soc Pharm. 2023 Aug 5;11:100315. doi: 10.1016/j.rcsop.2023.100315. eCollection 2023 Sep.
3
Role of home blood pressure monitoring in resistant hypertension.

本文引用的文献

1
Patterns of nonadherence to antihypertensive therapy in primary care.基层医疗中抗高血压治疗的不依从模式。
J Clin Hypertens (Greenwich). 2013 Feb;15(2):107-11. doi: 10.1111/jch.12030. Epub 2012 Oct 26.
2
Prevalence and clinical profile of resistant hypertension among treated hypertensive subjects.治疗高血压患者中耐药性高血压的患病率和临床特征。
Clin Exp Hypertens. 2013;35(6):412-7. doi: 10.3109/10641963.2012.739236. Epub 2012 Nov 13.
3
Optimizing blood pressure control in hypertension: the need to use ABPM.优化高血压的血压控制:使用动态血压监测的必要性。
家庭血压监测在顽固性高血压中的作用。
Clin Hypertens. 2023 Jan 15;29(1):2. doi: 10.1186/s40885-022-00226-1.
4
Immune Mechanisms of Dietary Salt-Induced Hypertension and Kidney Disease: Harry Goldblatt Award for Early Career Investigators 2020.膳食盐诱导的高血压和肾病的免疫机制:2020 年哈里·戈德布拉特早期职业研究者奖。
Hypertension. 2021 Aug;78(2):252-260. doi: 10.1161/HYPERTENSIONAHA.121.16495. Epub 2021 Jul 7.
5
Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?高血压:炎症与免疫能成为解决这场流行病的关键吗?
Circ Res. 2021 Apr 2;128(7):908-933. doi: 10.1161/CIRCRESAHA.121.318052. Epub 2021 Apr 1.
6
Hypothesis: Unrecognized actions of ENaC blockade in improving refractory-resistant hypertension and residual cardiovascular risk.假设:上皮钠通道(ENaC)阻滞剂在改善难治性高血压和残余心血管风险方面存在未被认识的作用。
Int J Cardiol Hypertens. 2020 Sep 12;7:100048. doi: 10.1016/j.ijchy.2020.100048. eCollection 2020 Dec.
7
Reserpine Substantially Lowers Blood Pressure in Patients With Refractory Hypertension: A Proof-of-Concept Study.利血平可显著降低难治性高血压患者的血压:一项概念验证研究。
Am J Hypertens. 2020 Aug 4;33(8):741-747. doi: 10.1093/ajh/hpaa042.
8
Antihypertensive Medication Adherence and Confirmation of True Refractory Hypertension.抗高血压药物的依从性与真性难治性高血压的确诊。
Hypertension. 2020 Feb;75(2):510-515. doi: 10.1161/HYPERTENSIONAHA.119.14137. Epub 2019 Dec 9.
9
The prevalence and predictors of resistant hypertension in high-risk overweight and obese patients: A cross-sectional study based on the 2017 ACC/AHA guidelines.超重和肥胖高危患者中耐药性高血压的患病率及其预测因素:基于 2017ACC/AHA 指南的横断面研究。
J Clin Hypertens (Greenwich). 2019 Oct;21(10):1507-1515. doi: 10.1111/jch.13666. Epub 2019 Aug 26.
10
Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence.未控制的高血压并非归因于药物不依从。
Hypertension. 2019 Sep;74(3):652-659. doi: 10.1161/HYPERTENSIONAHA.119.13258. Epub 2019 Jul 22.
Blood Press. 2013 Apr;22(2):65-72. doi: 10.3109/08037051.2012.727253. Epub 2012 Oct 4.
4
Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension.表观治疗抵抗性高血压患者中低药物治疗依从性的流行情况及其相关因素。
J Clin Hypertens (Greenwich). 2012 Oct;14(10):694-700. doi: 10.1111/j.1751-7176.2012.00690.x. Epub 2012 Aug 3.
5
Beta-blockers for hypertension.用于治疗高血压的β受体阻滞剂。
Cochrane Database Syst Rev. 2012 Aug 15(8):CD002003. doi: 10.1002/14651858.CD002003.pub3.
6
Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs.抗高血压药物治疗抵抗患者与接受三联及三联以下药物治疗且血压控制良好患者的临床差异。
J Hypertens. 2012 Jun;30(6):1211-6. doi: 10.1097/HJH.0b013e328353634e.
7
Predictors of antihypertensive medication adherence in two urban health-care systems.两种城市医疗体系中降压药物治疗依从性的预测因素。
Am J Hypertens. 2012 Jul;25(7):735-8. doi: 10.1038/ajh.2012.30. Epub 2012 Mar 22.
8
Incidence and prognosis of resistant hypertension in hypertensive patients.高血压患者中耐药性高血压的发生率和预后。
Circulation. 2012 Apr 3;125(13):1635-42. doi: 10.1161/CIRCULATIONAHA.111.068064. Epub 2012 Feb 29.
9
Refractory hypertension: definition, prevalence, and patient characteristics.难治性高血压:定义、患病率和患者特征。
J Clin Hypertens (Greenwich). 2012 Jan;14(1):7-12. doi: 10.1111/j.1751-7176.2011.00556.x. Epub 2011 Nov 15.
10
Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents.描述了抗高血压药物在服用四种或以上药物的难治性高血压患者中的使用情况。
Hypertension. 2011 Dec;58(6):1008-13. doi: 10.1161/HYPERTENSIONAHA.111.180497. Epub 2011 Oct 31.